General Proximity is a biotechnology company pioneering next-generation induced proximity medicines. It controls biological processes through proximity to redefine the future of medicine, targeting undruggable proteins associated with diseases like cancer and cardiometabolic disease.
- Category
- Induced proximity medicines
- Stage
- Seed
- Employees
- 21
- HQ
- San Francisco, United States
- Founded
- 2019
- Funding
- $16M